Ginsenoside Rh2 downregulates LPS-induced NF- B activation through inhibition of TAK1 phosphorylation in RAW 264.7 murine macrophage

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Lian, Li Hua ^a   Jin, Quan ^a   Song, Shun Zong ^a   Wu, Yan Ling ^a   Bai, Ting ^a   Jiang, Shuang ^a   Li, Qian ^a   Yang, Ning ^a   Nan, Ji Xing ^a  

^a YANBIAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; GINSENOSIDE RH 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOWN REGULATION; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 84874898980     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/646728     Document Type: Article

References (35)

1. Ulevitch R. J., Tobias P. S., Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annual Review of Immunology 1995 13 437 457 2-s2.0-0028965644
2. Qureshi S. T., Larivière L., Leveque G., Clermont S., Moore K. J., Gros P., Malo D., Endotoxin-tolerant mice have mutations in toll-like receptor 4 (Tlr4). Journal of Experimental Medicine 1999 189 4 615 625 2-s2.0-0345561540 10.1084/jem.189.4.615 (Pubitemid 29193362)
3. Jiang Q., Akashi S., Miyake K., Petty H. R., Cutting edge: lipopolysaccharide induces physical proximity between CD14 and Toll-like receptor 4 (TLR4) prior to nuclear translocation of NF- B. Journal of Immunology 2000 165 7 3541 3544 2-s2.0-0034292364 (Pubitemid 32057253)
4. Frobøse H., Rønn S. G., Heding P. E., Mendoza H., Cohen P., Mandrup-Poulsen T., Billestrup N., Suppressor of cytokine signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Molecular Endocrinology 2006 20 7 1587 1596 2-s2.0-33745194935 10.1210/me.2005-0301 (Pubitemid 43967566)
5. Frede S., Stockmann C., Freitag P., Fandrey J., Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF- B. Biochemical Journal 2006 396 3 517 527 2-s2.0-33745003285 10.1042/BJ20051839 (Pubitemid 44228166)
6. Peyssonnaux C., Johnson R. S., An unexpected role for hypoxic response: oxygenation and inflammation. Cell Cycle 2004 3 2 168 171 2-s2.0-3843079885 (Pubitemid 40268691)
7. Chu S. F., Zhang J. T., New achievements in ginseng research and its future prospects. Chinese Journal of Integrative Medicine 2009 15 6 403 408 2-s2.0-73849150347 10.1007/s11655-009-0403-6
8. Su J. H., Xu J. H., Wang Z. L., Improving enzymatic production of ginsenoside Rh2 from Rg3 by using nonionic surfactant. Applied Biochemistry and Biotechnology 2010 160 4 1116 1123 2-s2.0-77949285695 10.1007/s12010-009-8570-7
9. Li B., Zhao J., Wang C. Z., Searle J., He T. C., Yuan C. S., Du W., Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Letters 2011 301 2 185 192 2-s2.0-78651445610 10.1016/j.canlet.2010.11.015
10. Ham Y. M., Lim J. H., Na H. K., Choi J. S., Park B. D., Yim H., Lee S. K., Ginsenoside-Rh2-induced mitochondrial depolarization and apoptosis are associated with reactive oxygen species- and Ca2+-mediated c-Jun NH2-terminal kinase 1 activation in HeLa cells. Journal of Pharmacology and Experimental Therapeutics 2006 319 3 1276 1285 2-s2.0-33751183316 10.1124/jpet.106.109926
11. Oh J. I., Chun K. H., Joo S. H., Oh Y. T., Lee S. K., Caspase-3-dependent protein kinase C delta activity is required for the progression of Ginsenoside-Rh2-induced apoptosis in SK-HEP-1 cells. Cancer Letters 2005 230 2 228 238 2-s2.0-27744525803 10.1016/j.canlet.2004.12.043 (Pubitemid 41612466)
12. Choi S., Kim T. W., Singh S. V., Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1 -dependent Inhibition of Cyclin-dependent Kinases. Pharmaceutical Research 2009 26 10 2280 2288 2-s2.0-69949130845 10.1007/s11095-009-9944-9
13. Hwang J. T., Kim S. H., Lee M. S., Kim S. H., Yang H. J., Kim M. J., Kim H. S., Ha J., Kim M. S., Kwon D. Y., Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte. Biochemical and Biophysical Research Communications 2007 364 4 1002 1008 2-s2.0-36148962915 10.1016/j.bbrc.2007.10.125 (Pubitemid 350103699)
14. Park J. S., Park E. M., Kim D. H., Jung K., Jung J. S., Lee E. J., Hyun J. W., Kang J. L., Kim H. S., Anti-inflammatory mechanism of ginseng saponins in activated microglia. Journal of Neuroimmunology 2009 209 1-2 40 49 2-s2.0-64549126462 10.1016/j.jneuroim.2009.01.020
15. Choi K., Kim M., Ryu J., Choi C., Ginsenosides compound K and Rh2 inhibit tumor necrosis factor- α -induced activation of the NF- B and JNK pathways in human astroglial cells. Neuroscience Letters 2007 421 1 37 41 2-s2.0-34250161282 10.1016/j.neulet.2007.05.017 (Pubitemid 46899328)
16. Marchant A., Duchow J., Delville J. P., Goldman M., Lipopolysaccharide induces up-regulation of CD14 molecule on monocytes in human whole blood. European Journal of Immunology 1992 22 6 1663 1665 2-s2.0-0026551423 10.1002/eji.1830220650
17. Matsuura K., Ishida T., Setoguchi M., Higuchi Y., Akizuki S., Yamamoto S., Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide. Journal of Experimental Medicine 1994 179 5 1671 1676 2-s2.0-0028331784 (Pubitemid 24129585)
18. Bi W.-Y., Fu B.-D., Shen H.-Q., Wei Q., Zhang C., Song Z., Qin Q.-Q., Li H.-P., Lv S., Wu S.-C., Yi P.-F., Wei X.-B., Sulfated derivative of 20(S)-Ginsenoside Rh2 inhibits inflammatory cytokines through MAPKs and NF-kappa B pathways in LPS-Induced RAW264.7 macrophages. Inflammation 2012 35 5 1659 1668 10.1007/s10753-012-9482-1
19. Lee K.-W., Jung S. Y., Choi S.-M., Yang E. J., Effects of ginsenoside Re on LPS-induced inflammatory mediators in BV2 microglial cells. BMC Complementary and Alternative Medicine 2012 12, article 196 10.1186/1472-6882-12-196
20. Wu C. F., Bi X. L., Yang J. Y., Zhan J. Y., Dong Y. X., Wang J. H., Wang J. M., Zhang R., Li X., Differential effects of ginsenosides on NO and TNF- α production by LPS-activated N9 microglia. International Immunopharmacology 2007 7 3 313 320 10.1016/j.intimp.2006.04.021 (Pubitemid 46186170)
21. Park E. K., Shin Y. W., Lee H. U., Kim S. S., Lee Y. C., Lee B. Y., Kim D. H., Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. Biological and Pharmaceutical Bulletin 2005 28 4 652 656 2-s2.0-21144444049 10.1248/bpb.28.652 (Pubitemid 40879932)
22. Bae E. A., Han M. J., Choo M. K., Park S. Y., Kim D. H., Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biological and Pharmaceutical Bulletin 2002 25 1 58 63 2-s2.0-0036370799
23. Shin Y.-M., Jung H.-J., Choi W.-Y., Lim C.-J., Antioxidative, anti-inflammatory, and matrix metalloproteinase inhibitory activities of 20(S)-ginsenoside Rg3 in cultured mammalian cell lines. Molecular Biology Reports 2013 40 1 269 279 10.1007/s11033-012-2058-1
24. Hien T. T., Kim N. D., Kim H. S., Kang K. W., Ginsenoside Rg3 inhibits tumor necrosis factor- α -induced expression of cell adhesion molecules in human endothelial cells. Pharmazie 2010 65 9 699 701 2-s2.0-77957976228 10.1691/ph.2010.0569
25. Park E. K., Choo M. K., Oh J. K., Ryu J. H., Kim D. H., Ginsenoside Rh2 reduces ischemic brain injury in rats. Biological and Pharmaceutical Bulletin 2004 27 3 433 436 2-s2.0-4544352951 10.1248/bpb.27.433 (Pubitemid 41685495)
26. Bae E. A., Kim E. J., Park J. S., Kim H. S., Ryu J. H., Kim D. H., Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon- γ -stimulated BV-2 microglial cells. Planta Medica 2006 72 7 627 633 2-s2.0-33745683962 10.1055/s-2006-931563
27. Yamaguchi K., Shirakabe K., Shibuya H., Irie K., Oishi I., Ueno N., Taniguchi T., Nishida E., Matsumoto K., Identification of a member of the MAPKKK family as a potential Mediator of TGF- β signal transduction. Science 1995 270 5244 2008 2011 2-s2.0-0029551805 (Pubitemid 26097194)
28. Choi H. S., Cho D. I., Choi H. K., Im S. Y., Ryu S. Y., Kim K. M., Molecular mechanisms of inhibitory activities of tanshinones on lipopolysaccharide-induced nitric oxide generation in RAW 264.7 cells. Archives of Pharmacal Research 2004 27 12 1233 1237 2-s2.0-13744259982
29. Van Der Bruggen T., Nijenhuis S., Van Raaij E., Verhoef J., Van Asbeck B. S., Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the Raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infection and Immunity 1999 67 8 3824 3829 2-s2.0-0032806197 (Pubitemid 29356998)
30. Andersson K., Sundler R., Signalling to translational activation of tumour necrosis factor- α expression in human THP-1 cells. Cytokine 2000 12 12 1784 1787 2-s2.0-0034534079 10.1006/cyto.2000.0784 (Pubitemid 32009691)
31. Fitzgerald K. A., Rowe D. C., Golenbock D. T., Endotoxin recognition and signal transduction by the TLR4/MD-2 complex. Microbes and Infection 2004 6 15 1361 1367 2-s2.0-16644372986 10.1016/j.micinf.2004.08.015 (Pubitemid 41110578)
32. Kerfoot S. M., Kubes P., Local coordination verses systemic disregulation: complexities in leukocyte recruitment revealed by local and systemic activation of TLR4 in vivo. Journal of Leukocyte Biology 2005 77 6 862 867 2-s2.0-20044373663 10.1189/jlb.1004607 (Pubitemid 40770836)
33. Bracken C. P., Whitelaw M. L., Peet D. J., The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses. Cellular and Molecular Life Sciences 2003 60 7 1376 1393 2-s2.0-0042368882 10.1007/s00018-003-2370-y (Pubitemid 36900521)
34. Cramer T., Johnson R. S., A novel role for the hypoxia inducible transcription factor HIF-1alpha: critical regulation of inflammatory cell function. Cell Cycle 2003 2 3 192 193 2-s2.0-0141834798
35. Hollander A. P., Corke K. P., Freemont A. J., Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis and Rheumatism 2001 44 7 1540 1544 (Pubitemid 32642216)